Human RASAL1/RASAL ORF/cDNA clone-Lentivirus plasmid (NM_001193521.1)
Cat. No.: pGMLP005659
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human RASAL1/RASAL Lentiviral expression plasmid for RASAL1 lentivirus packaging, RASAL1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
RASAL1/RASAL products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMLP005659 |
Gene Name | RASAL1 |
Accession Number | NM_001193521.1 |
Gene ID | 8437 |
Species | Human |
Product Type | Lentivirus plasmid (overexpression) |
Insert Length | 2331 bp |
Gene Alias | RASAL |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGCCAAGAGCAGCTCCCTGAATGTTCGCGTGGTGGAGGGCCGCGCGCTGCCTGCCAAGGACGTGTCTGGGAGCAGCGACCCCTACTGCCTAGTGAAAGTGGACGACGAGGTGGTGGCCAGGACAGCTACTGTCTGGAGGAGCCTGGGCCCCTTCTGGGGGGAGGAGTACACGGTGCACCTGCCTCTGGATTTCCACCAGCTGGCCTTCTACGTGCTGGATGAGGACACTGTCGGGCACGACGACATCATCGGCAAGATCTCGCTGAGCAGGGAGGCGATTACAGCCGACCCCCGAGGGATTGACAGCTGGATTAACTTGAGCCGAGTGGACCCAGATGCAGAAGTGCAGGGTGAGATCTGCCTGTCAGTGCAGATGCTGGAGGATGGGCAGGGCCGCTGCCTTCGCTGCCATGTGCTTCAGGCCAGGGACCTGGCTCCCAGAGACATCTCTGGCACATCTGACCCATTTGCACGTGTGTTTTGGGGCAGCCAGAGCTTGGAGACCTCAACCATCAAGAAGACTCGCTTCCCGCACTGGGATGAAGTGCTGGAGCTGCGGGAGATGCCAGGTGCCCCGTCCCCACTGCGGGTGGAGCTCTGGGACTGGGACATGGTGGGCAAGAATGACTTCTTGGGCATGGTGGAGTTCTCTCCAAAGACCCTCCAGCAGAAGCCACCTAAAGGCTGGTTCCGCCTCCTGCCCTTTCCCAGAGCCGAGGAGGATTCTGGGGGGAACCTGGGTGCCCTGCGAGTGAAGGTACGCCTGATTGAGGACCGCGTCCTGCCCTCCCAGTGCTACCAGCCTCTCATGGAGCTGCTCATGGAGTCTGTGCAGGGGCCAGCAGAGGAGGACACTGCTAGCCCCTTGGCTTTGCTGGAAGAGCTGACCTTGGGGGACTGCCGCCAGGACCTTGCCACCAAGCTGGTGAAACTCTTTCTTGGCCGGGGACTGGCTGGGCGCTTTCTGGACTATCTCACCCGGCGTGAGGTGGCTCGGACCATGGACCCCAACACCCTCTTCCGTTCTAACTCCCTGGCATCCAAGTCGATGGAACAGTTTATGAAGCTCGTGGGCATGCCCTACCTGCACGAGGTCCTGAAGCCTGTGATTAGCCGTGTCTTTGAGGAGAAGAAGTACATGGAGCTGGATCCCTGCAAGATGGACCTGGGCCGCACCCGGAGGATCTCCTTCAAAGGCGCACTCTCGGAGGAGCAGATGCGGGAGACCAGCCTGGGGCTGCTGACGGGCTACCTGGGGCCCATCGTGGACGCCATCGTGGGCTCCGTGGGGCGCTGCCCGCCCGCCATGCGCCTCGCCTTCAAGCAGCTGCACCGGCGAGTGGAGGAGCGCTTCCCCCAGGCCGAGCACCAGGATGTGAAGTACCTGGCCATCAGTGGATTTCTCTTCTTGCGATTCTTCGCACCTGCCATCCTTACCCCAAAGCTGTTTGACCTTCGGGACCAACACGCGGACCCCCAGACTAGCCGCTCACTGCTGTTGCTTGCCAAGGCTGTGCAGAGCATTGGAAACCTGGGCCAGCAGCTGGGCCAAGGCAAGGAACTGTGGATGGCCCCCCTGCACCCCTTCCTGCTGCAGTGTGTCTCACGTGTGAGAGACTTCCTGGACCGGCTGGTGGATGTGGATGGGGATGAAGCTGGTGTCCCAGCCAGGGCCCTGTTCCCGCCCTCGGCCATTGTTCGAGAAGGCTATCTGCTGAAGCGCAAGGAGGAGCCTGCCGGCCTGGCCACGCGCTTTGCCTTCAAGAAGCGCTACGTCTGGCTCAGCGGGGAGACCCTCTCCTTCTCCAAGAGTCCTGAGTGGCAGGTGGTGACGCAGGACGGCACGGGGGCGCTGCACACCACCTACCTCCAGTGCAAGAATGTGAATGAGCTCAACCAGTGGCTCTCGGCCTTGCGCAAGGCCAGCGCCCCCAACCCGAACAAGCTGGCCGCCTGCCACCCCGGTGCCTTCCGCAGCGCGCGCTGGACCTGCTGCCTCCAGGCTGAGCGCTCAGCCGCCGGCTGCAGCCGTACACACTCAGCTGTCACCCTGGGGGACTGGAGTGACCCACTGGATCCTGATGCTGAGGCCCAGACAGTGTATCGGCAGCTGCTCCTGGGGCGGGACCAGCTCAGGCTGAAATTACTGGAGGATTCTAACATGGATACAACTCTGGAGGCAGACACAGGGGCCTGTCCTGAGGTCCTGGCCCGGCAAAGAGCAGCAACTGCCCGCCTGCTGGAGGTGCTCGCAGACCTGGATCGTGCCCACGAGGAGTTCCAGCAGCAGGAGCGAGGGAAGGCGGCCCTGGGCCCCCTTGGCCCCTAA |
ORF Protein Sequence | MAKSSSLNVRVVEGRALPAKDVSGSSDPYCLVKVDDEVVARTATVWRSLGPFWGEEYTVHLPLDFHQLAFYVLDEDTVGHDDIIGKISLSREAITADPRGIDSWINLSRVDPDAEVQGEICLSVQMLEDGQGRCLRCHVLQARDLAPRDISGTSDPFARVFWGSQSLETSTIKKTRFPHWDEVLELREMPGAPSPLRVELWDWDMVGKNDFLGMVEFSPKTLQQKPPKGWFRLLPFPRAEEDSGGNLGALRVKVRLIEDRVLPSQCYQPLMELLMESVQGPAEEDTASPLALLEELTLGDCRQDLATKLVKLFLGRGLAGRFLDYLTRREVARTMDPNTLFRSNSLASKSMEQFMKLVGMPYLHEVLKPVISRVFEEKKYMELDPCKMDLGRTRRISFKGALSEEQMRETSLGLLTGYLGPIVDAIVGSVGRCPPAMRLAFKQLHRRVEERFPQAEHQDVKYLAISGFLFLRFFAPAILTPKLFDLRDQHADPQTSRSLLLLAKAVQSIGNLGQQLGQGKELWMAPLHPFLLQCVSRVRDFLDRLVDVDGDEAGVPARALFPPSAIVREGYLLKRKEEPAGLATRFAFKKRYVWLSGETLSFSKSPEWQVVTQDGTGALHTTYLQCKNVNELNQWLSALRKASAPNPNKLAACHPGAFRSARWTCCLQAERSAAGCSRTHSAVTLGDWSDPLDPDAEAQTVYRQLLLGRDQLRLKLLEDSNMDTTLEADTGACPEVLARQRAATARLLEVLADLDRAHEEFQQQERGKAALGPLGP |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-MP2283-Ab | Anti-RASL1/ RASAL1/ RASAL monoclonal antibody |
Target Antigen | GM-Tg-g-MP2283-Ag | RASAL1 VLP (virus-like particle) |
ORF Viral Vector | pGMLP005659 | Human RASAL1 Lentivirus plasmid |
ORF Viral Vector | vGMLP005659 | Human RASAL1 Lentivirus particle |
Target information
Target ID | GM-MP2283 |
Target Name | RASAL1 |
Gene ID | 8437, 19415, 714353, 360814, 101088621, 486277, 512872, 100056699 |
Gene Symbol and Synonyms | MRASAL,RASAL,RASAL1 |
Uniprot Accession | O95294 |
Uniprot Entry Name | RASL1_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Not Available |
Disease | Cancer |
Gene Ensembl | ENSG00000111344 |
Target Classification | Tumor-associated antigen (TAA) |
The protein encoded by this gene is member of the GAP1 family of GTPase-activating proteins. These proteins stimulate the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. This particular family member contains domains which are characteristic of the GAP1 subfamily of RasGAP proteins but, in contrast to the other GAP1 family members, this protein is strongly and selectively expressed in endocrine tissues. Alternatively spliced transcript variants that encode different isoforms have been described [provided by RefSeq, Jul 2010]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.